Hubertus von Baumbach

Chairman of the Board of Managing Directors

Law degree and second state exam, MBA

Professional milestones

2012 – 2016     Member of the Board of Managing Directors with responsibility for Finance, Boehringer Ingelheim

2009 – 2012     Member of the Board of Managing Directors with responsibility for Finance and Animal Health, Boehringer Ingelheim

2006 – 2008     Vice President Finance, Boehringer Ingelheim Deutschland

2003 – 2005     Head of department Controlling Subsidiaries, Boehringer Ingelheim

2002 – 2003     Head of group Controlling CHC, Boehringer Ingelheim

Since 2001     Employee of Boehringer Ingelheim

*2 February 1974
PhD in Molecular Pharmacology, Vrije Universiteit Amsterdam, The Netherlands 
MSc in Medicinal Chemistry, Università di Torino, Italy

Professional milestones

2020 – 2023 Global Head of Therapeutic Areas

2019 - 2020 Global Therapeutic Area Head CNS, Retinopathy and Emerging areas

2019 - Head of Research Site Biberach, Germany

2014 - 2018 Global Head of Business Development, Prescription Medicine

2013 - 2014 Head of Therapeutic Alliances and Strategic Partnerships

2010 - 2013 Global Head Business Development and Licensing for Respiratory

2004 - 2010 Various Research roles at Boehringer Ingelheim and Organon (MSD)

*1 April 1973
Diplom-Kaufmann (Masters’ degree in Business Administration), University of Hamburg, Hamburg, Germany

Professional milestones

2024 Member of the Board of Managing Directors with responsibility for the Animal Health Business Unit

2022 - 2023 Country Managing Director, Japan

2020 - 2022 Head of Human Pharma, Japan

2019 - 2020 Head of Specialty Care, Japan

2017 - 2019 Head of Marketing, Japan

2014 - 2017 Head of Diabetes Marketing, Japan

2012 - 2014 Global Brand Team Leader Trajenta® (Ingelheim, Germany)

2002 - 2012 Various roles in US and Global Marketing at Sanofi, US

1999 - 2002 Strategy consultant at Cap Gemini, Germany

* July 18, 1971
Master of Science degree in Business Administration
from the Catholic University Eichstätt, Ingolstadt, Germany

Professional milestones

2019 – present    Head of Corporate Finance, Accounting, Controlling & Tax

2017 – 2019    Head of Corporate Controlling

2015 – 2017    Project Leadership Boehringer Ingelheim CHC/ Sanofi Merial swap transaction
 

2013 – 2015    Head of Global Reporting & Planning

2011 – 2013    Head of Finance & Administration UK & Ireland, Bracknell, UK

2007 – 2011    Head of Controlling Regional Center Vienna, Vienna, Austria

2005 – 2007    Senior Manager Internal Auditing, Burlington, Canada

*17 June 1964
Master Degree in Aerospace Technologies and Mechanical Engineering, Master Degree in Industrial Engineering

Professional milestones

2016 – today     Founder and Managing Director of BI X, the digital lab of Boehringer Ingelheim

2012 – 2017     CIO, Corporate Senior Vice President Information Technology, Boehringer Ingelheim

2006 – 2012     Corporate Vice President IT & CIO, Infineon AG

2003 – 2006     Vice President IT Business Transformation, Infineon AG

2000 – 2003     Vice President Logistics & Supply Chain Management IT Systems, Infineon AG

1999 – 2000     Senior Director of Supply Chain Management Competence Center IT, Infineon AG

*12 June 1974
Doctoral and Master of Science degrees in Economics 
from the Albert-Ludwigs University Freiburg, Germany

Professional milestones

2021 – 2024     Country Managing Director & Head of Animal Health Southeast Asia, Korea, Australia and New Zealand, based in Singapore

2020                      Head of Animal Health, region Southeast Asia and Korea, based in Singapore

2016 – 2020     General Manager Boehringer Ingelheim & Head of Human Pharma, Thailand

2014 – 2016     Regional Business Manager U.S. and Canada, based in Ingelheim, Germany

2010 – 2014     Human Pharma marketing leadership roles in Ingelheim, Germany & Ridgefield, U.S.

2008 – 2010     Head of Corporate Strategy & PMO, Corporate Development, Ingelheim, Germany

2001 – 2007     McKinsey & Company, Germany